Shares of AdaptHealth Corp. (NASDAQ: AHCO) plummeted 16.45% in pre-market trading on Monday, after the healthcare services company reported mixed third-quarter results and lowered its full-year revenue guidance.
For the third quarter, AdaptHealth posted earnings of $0.40 per share, surpassing analysts' estimates of $0.17 per share. However, the company's revenue of $805.9 million fell short of expectations, missing the consensus estimate of $809.3 million.
More concerning for investors, AdaptHealth slashed its fiscal 2024 revenue guidance to a range of $3.22 billion to $3.26 billion, down from its previous forecast of $3.26 billion to $3.32 billion. The lowered guidance overshadowed the company's better-than-expected earnings, leading to a sharp sell-off in the stock.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。